TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005
TCL Archive Study: Delaying ADT Until Symptoms Appear Can Be Safe in Men with a PSA-based Relapse May 30, 2014
TCL Archive Improved NCI Relations With FDA Cited As Model For Government Accord, Lasagna Committee Says April 20, 1990
